Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales
The Swiss drugmaker raised its full-year guidance Tuesday projecting net sales to grow in the high-single to low double-digit range while reporting better-than-expected first-quarter results.